IGLC1 and chronic myelogenous leukemia, BCR-ABL1 positive: [104] in a SNP array analysis of tyrosine kinase inhibitor-resistant CML identified some secondary genomic abnormalities, including newly acquired and recurrent deletions of the IGLC1 locus.